TruBridge (NASDAQ:TBRG) Releases Earnings Results, Misses Estimates By $0.34 EPS

TruBridge (NASDAQ:TBRGGet Free Report) posted its quarterly earnings results on Monday. The company reported ($0.05) EPS for the quarter, missing the consensus estimate of $0.29 by ($0.34), Zacks reports. TruBridge had a negative net margin of 17.72% and a positive return on equity of 1.78%. TruBridge updated its FY 2025 guidance to EPS and its Q1 2025 guidance to EPS.

TruBridge Price Performance

Shares of TBRG traded down $0.94 during trading hours on Monday, reaching $27.37. 354,540 shares of the company traded hands, compared to its average volume of 126,478. The stock has a market capitalization of $408.50 million, a PE ratio of -6.69, a price-to-earnings-growth ratio of 5.38 and a beta of 0.71. The stock has a fifty day simple moving average of $24.92 and a 200 day simple moving average of $18.11. TruBridge has a fifty-two week low of $7.61 and a fifty-two week high of $31.67. The company has a quick ratio of 1.78, a current ratio of 1.80 and a debt-to-equity ratio of 1.00.

Insider Buying and Selling at TruBridge

In other news, major shareholder Pinetree Capital Ltd. purchased 6,795 shares of the stock in a transaction dated Tuesday, February 18th. The stock was acquired at an average cost of $28.16 per share, for a total transaction of $191,347.20. Following the completion of the acquisition, the insider now directly owns 729,176 shares in the company, valued at $20,533,596.16. This represents a 0.94 % increase in their position. The purchase was disclosed in a document filed with the Securities & Exchange Commission, which is available at the SEC website. In the last ninety days, insiders have bought 116,728 shares of company stock worth $3,239,879. Corporate insiders own 3.60% of the company’s stock.

Analyst Upgrades and Downgrades

Several brokerages recently commented on TBRG. Stephens raised their price objective on shares of TruBridge from $13.00 to $17.00 and gave the company an “equal weight” rating in a research note on Wednesday, November 20th. Barclays lifted their price target on shares of TruBridge from $10.00 to $14.00 and gave the company an “equal weight” rating in a research report on Monday, November 11th.

Check Out Our Latest Stock Report on TBRG

TruBridge Company Profile

(Get Free Report)

TruBridge, Inc provides healthcare solutions and services for community hospitals, clinics, and other healthcare systems in the United States and internationally. The company operates in three segments: Revenue Cycle Management (RCM), Electronic Health Record (HER), and Patient Engagement. It focuses on providing RCM solutions for care settings, regardless of primary healthcare information solutions provider along with business management, consulting, managed IT services, and analytics and business intelligence.

Read More

Earnings History for TruBridge (NASDAQ:TBRG)

Receive News & Ratings for TruBridge Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for TruBridge and related companies with MarketBeat.com's FREE daily email newsletter.